{"id":6568,"date":"2022-10-21T09:56:56","date_gmt":"2022-10-21T07:56:56","guid":{"rendered":"https:\/\/nanexa.com\/?page_id=6568"},"modified":"2022-12-01T15:16:27","modified_gmt":"2022-12-01T14:16:27","slug":"nex-22","status":"publish","type":"page","link":"https:\/\/nanexa.com\/sv\/nex-22\/","title":{"rendered":"NEX-22"},"content":{"rendered":"\n<div class=\"block-project full-width-container alignfull\">\n\t<div class=\"block-project-list\">\n\t\t<div class=\"block-project-list-left\">\n\t\t\t<div class=\"block-project-list-heading\">\n\t\t\t\t\n\n<h1 class=\"wp-block-heading\" id=\"nex-20-for-the-treatment-of-mm\"><span>nex-22<\/span> f\u00f6r behandling <br>av typ 2-diabetes<br><span class=\"small-span\"><\/span><\/h1>\n\n\n\t\t\t<\/div>\n\t\t\t<div class=\"project-list\">\n\t\t\t\t\t\t\t\t\t\t\t\t<ol><li><a href=\"#project-id-1\">Vad \u00e4r typ 2-diabetes<\/a><\/li><li><a href=\"#project-id-2\">B\u00e4ttre efterlevnad och bekv\u00e4mare behandling<\/a><\/li>\t\t\t\t<\/ol>\t\t\t<\/div>\n\t\t<\/div>\n\t\t<div class=\"block-project-list-image\">\n\t\t\t<img decoding=\"async\" src=\"https:\/\/nanexa.com\/wp-content\/uploads\/2022\/10\/typ2diabetes_1.webp\" style=\"width:100%\">\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<section class=\"project-section\"><div class=\"nex-border\"><\/div><div class=\"nex-section-rubrik\"><p>vad \u00e4r<\/p><\/div><div class=\"block-project-heading\">\n\n<h2 class=\"wp-block-heading\" id=\"what-is-mm\">VAD \u00c4R <span>typ 2-diabetes?<\/span><\/h2>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:66.66%\">\n<h3 class=\"wp-block-heading\">Typ 2-diabetes \u00e4r en metabol sjukdom d\u00e4r kroppen har sv\u00e5rt att reglera sockerhalten vilket leder till h\u00f6ga blodsockerv\u00e4rden.<\/h3>\n\n\n\n<p>Sjukdomen uppkommer fr\u00e4mst i \u00f6vre medel\u00e5ldern (&gt;45 \u00e5r) men f\u00f6rekomsten \u00f6kar i yngre \u00e5r som en f\u00f6ljd av alltmer stillasittande och osund kost. Vanliga symtom \u00e4r bland annat tr\u00f6tthet, \u00f6kad t\u00f6rst och frekvent urinering. Symtomen kommer ofta l\u00e5ngsamt och kan ibland vara sv\u00e5ra att m\u00e4rka.<\/p>\n\n\n\n<p>Typ 2-diabetes kan ge en rad allvarliga f\u00f6ljdsjukdomar, s\u00e5som njurskador, nedsatt syn och hj\u00e4rtsjukdomar. Behandling \u00e4r d\u00e4rf\u00f6r avg\u00f6rande, b\u00e5de f\u00f6r patienternas allm\u00e4nna v\u00e4lm\u00e5ende och f\u00f6r att h\u00e5lla nere kostnader f\u00f6r sjukv\u00e5rden och samh\u00e4llet.<\/p>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:33.33%\">\n<figure class=\"wp-block-image size-full\"><a href=\"https:\/\/nanexa.com\/wp-content\/uploads\/2022\/10\/typ2diabetes_2.webp\"><img loading=\"lazy\" decoding=\"async\" width=\"450\" height=\"338\" src=\"https:\/\/nanexa.com\/wp-content\/uploads\/2022\/10\/typ2diabetes_2.webp\" alt=\"\" class=\"wp-image-6575\" srcset=\"https:\/\/nanexa.com\/wp-content\/uploads\/2022\/10\/typ2diabetes_2.webp 450w, https:\/\/nanexa.com\/wp-content\/uploads\/2022\/10\/typ2diabetes_2-300x225.webp 300w\" sizes=\"auto, (max-width: 450px) 100vw, 450px\" \/><\/a><\/figure>\n<\/div>\n<\/div>\n\n\n\n<h3 class=\"wp-block-heading\"><strong><span class=\"red-bold-span\">F\u00d6REKOMST<\/span><\/strong><\/h3>\n\n\n\n<div class=\"wp-block-columns break-desktop is-layout-flex wp-container-core-columns-is-layout-9d6595d7 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:60%\">\n<p>Typ 2-diabetes \u00e4r en av v\u00e5ra vanligaste folksjukdomar d\u00e4r f\u00f6rekomsten \u00f6kar i takt med en \u00e5ldrande befolkning. Datamonitor Healthcare uppskattar att det globalt lever cirka 600 miljoner m\u00e4nniskor med typ 2-diabetes idag, en siffra som ber\u00e4knas \u00f6ka till 635 miljoner 2027 <sup>(1)<\/sup>.<\/p>\n\n\n<div class=\"visualizer-front-container visualizer-lazy-render\" id=\"chart_wrapper_visualizer-6587-485306610\"><style type=\"text\/css\" name=\"visualizer-custom-css\" id=\"customcss-visualizer-6587\">.locker,.locker-loader{position:absolute;top:0;left:0;width:100%;height:100%}.locker{z-index:1000;opacity:.8;background-color:#fff;-ms-filter:\"progid:DXImageTransform.Microsoft.Alpha(Opacity=80)\";filter:alpha(opacity=80)}.locker-loader{z-index:1001;background:url(https:\/\/nanexa.com\/wp-content\/plugins\/visualizer\/images\/ajax-loader.gif) no-repeat center center}.dt-button{display:none!important}.visualizer-front-container.visualizer-lazy-render{content-visibility: auto;}.google-visualization-controls-categoryfilter label.google-visualization-controls-label {vertical-align: middle;}.google-visualization-controls-categoryfilter li.goog-inline-block {margin: 0 0.2em;}.google-visualization-controls-categoryfilter li {padding: 0 0.2em;}.visualizer-front-container .dataTables_scrollHeadInner{margin: 0 auto;}.visualizer-editor-front-container{position:relative;width:auto;margin:5%;background:#fff}.visualizer-editor-front{overflow:hidden;width:100%;height:500px}.visualizer-editor-front-actions{padding-bottom:3px}.visualizer-editor-save,.visualizer-editor-cancel{margin:0 4px;padding:2px 15px}.visualizer-cw-error .visualizer-actions{display:none !important;} <\/style><div id=\"visualizer-6587-485306610\" class=\"visualizer-front  visualizer-front-6587\"><\/div><!-- Not showing structured data for chart 6587 because description is empty --><\/div>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:55%\">\n<p>Av de som lever med typ 2-diabetes blir tyv\u00e4rr inte alla diagnostiserade och antalet som inte f\u00e5r adekvat behandling \u00e4r \u00e4nnu st\u00f6rre. I de sju stora marknaderna i v\u00e4stv\u00e4rlden ber\u00e4knas cirka 50 miljoner personer bli behandlade med l\u00e4kemedel 2027 <sup>(3)<\/sup>, med en \u00f6kning p\u00e5 2-3% per \u00e5r.<\/p>\n\n\n<div class=\"visualizer-front-container visualizer-lazy-render\" id=\"chart_wrapper_visualizer-6615-2012683896\"><style type=\"text\/css\" name=\"visualizer-custom-css\" id=\"customcss-visualizer-6615\">.locker,.locker-loader{position:absolute;top:0;left:0;width:100%;height:100%}.locker{z-index:1000;opacity:.8;background-color:#fff;-ms-filter:\"progid:DXImageTransform.Microsoft.Alpha(Opacity=80)\";filter:alpha(opacity=80)}.locker-loader{z-index:1001;background:url(https:\/\/nanexa.com\/wp-content\/plugins\/visualizer\/images\/ajax-loader.gif) no-repeat center center}.dt-button{display:none!important}.visualizer-front-container.visualizer-lazy-render{content-visibility: auto;}.google-visualization-controls-categoryfilter label.google-visualization-controls-label {vertical-align: middle;}.google-visualization-controls-categoryfilter li.goog-inline-block {margin: 0 0.2em;}.google-visualization-controls-categoryfilter li {padding: 0 0.2em;}.visualizer-front-container .dataTables_scrollHeadInner{margin: 0 auto;}.visualizer-editor-front-container{position:relative;width:auto;margin:5%;background:#fff}.visualizer-editor-front{overflow:hidden;width:100%;height:500px}.visualizer-editor-front-actions{padding-bottom:3px}.visualizer-editor-save,.visualizer-editor-cancel{margin:0 4px;padding:2px 15px}.visualizer-cw-error .visualizer-actions{display:none !important;} <\/style><div id=\"visualizer-6615-2012683896\" class=\"visualizer-front  visualizer-front-6615\"><\/div><!-- Not showing structured data for chart 6615 because description is empty --><\/div>\n<\/div>\n<\/div>\n\n\n\n<h3 class=\"wp-block-heading\"><strong><span class=\"red-bold-span\">BEHANDLING<\/span><\/strong><\/h3>\n\n\n<div class=\"\"><img decoding=\"async\" class=\"image-right-float\" src=\"\"><\/div><div>\n\n<p>M\u00e5let med behandlingen vid typ 2-diabetes \u00e4r att f\u00e5 ner blodsockerv\u00e4rdet. Det g\u00e5r att g\u00f6ra med fysisk aktivitet och bra matvanor, men oftast beh\u00f6vs ocks\u00e5 l\u00e4kemedel. Det finns flera l\u00e4kemedel tillg\u00e4ngliga f\u00f6r att behandla typ 2-diabetes, men det \u00e4r ocks\u00e5 viktigt att \u00e4ndra sin livsstil genom intag av f\u00e4rre mindre kalorier och mer motion.<\/p>\n\n\n\n<p>En av de vanligaste l\u00e4kemedelsklasserna f\u00f6r behandling av typ 2-diabetes, \u00e4r GLP-1-analoger (glukagonlik peptid-1), som ges subkutant en g\u00e5ng per dag eller en g\u00e5ng per vecka. Liraglutid \u00e4r en GLP-1-analog som idag ges med dagliga injektioner.<\/p>\n\n\n\n<div class=\"wp-block-columns are-vertically-aligned-center break-desktop is-layout-flex wp-container-core-columns-is-layout-9d6595d7 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-vertically-aligned-center is-layout-flow wp-block-column-is-layout-flow\">\n<h3 class=\"wp-block-heading\"><span class=\"red-bold-span\">MARKNAD<\/span><\/h3>\n\n\n\n<p>F\u00f6rs\u00e4ljningen av l\u00e4kemedel mot typ 2-diabetes i de sju stora marknaderna i v\u00e4stv\u00e4rlden, ber\u00e4knas uppg\u00e5 till 50 miljarder dollar \u00e5r 2022, varav GLP-1-analoger st\u00e5r f\u00f6r ca 15 miljarder dollar och f\u00f6rv\u00e4ntas v\u00e4xa med omkring 10 procent per \u00e5r under perioden 2022-2029 <sup>(3)<\/sup>.<\/p>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-vertically-aligned-center is-layout-flow wp-block-column-is-layout-flow\"><div class=\"visualizer-front-container visualizer-lazy-render\" id=\"chart_wrapper_visualizer-6608-1858470618\"><style type=\"text\/css\" name=\"visualizer-custom-css\" id=\"customcss-visualizer-6608\">.locker,.locker-loader{position:absolute;top:0;left:0;width:100%;height:100%}.locker{z-index:1000;opacity:.8;background-color:#fff;-ms-filter:\"progid:DXImageTransform.Microsoft.Alpha(Opacity=80)\";filter:alpha(opacity=80)}.locker-loader{z-index:1001;background:url(https:\/\/nanexa.com\/wp-content\/plugins\/visualizer\/images\/ajax-loader.gif) no-repeat center center}.dt-button{display:none!important}.visualizer-front-container.visualizer-lazy-render{content-visibility: auto;}.google-visualization-controls-categoryfilter label.google-visualization-controls-label {vertical-align: middle;}.google-visualization-controls-categoryfilter li.goog-inline-block {margin: 0 0.2em;}.google-visualization-controls-categoryfilter li {padding: 0 0.2em;}.visualizer-front-container .dataTables_scrollHeadInner{margin: 0 auto;}.visualizer-editor-front-container{position:relative;width:auto;margin:5%;background:#fff}.visualizer-editor-front{overflow:hidden;width:100%;height:500px}.visualizer-editor-front-actions{padding-bottom:3px}.visualizer-editor-save,.visualizer-editor-cancel{margin:0 4px;padding:2px 15px}.visualizer-cw-error .visualizer-actions{display:none !important;} <\/style><div id=\"visualizer-6608-1858470618\" class=\"visualizer-front  visualizer-front-6608\"><\/div><!-- Not showing structured data for chart 6608 because description is empty --><\/div>\n<\/div>\n<\/div>\n\n<\/div>\n<\/div><\/section>\n\n<section class=\"project-section\"><div class=\"nex-border\"><\/div><div class=\"nex-section-rubrik\"><p>kontrollerad fris\u00e4ttning<\/p><\/div><div class=\"block-project-heading\">\n\n<h2 class=\"wp-block-heading\" id=\"controlled-release-increased-compliance\"><span class=\"red-bold-span\">NEX-22: <\/span>Kontrollerad fris\u00e4ttning ger b\u00e4ttre efterlevnad och bekv\u00e4mare behandling <\/h2>\n\n\n\n<p>NEX-22 \u00e4r en omformulering av liraglutid med en m\u00e5nads fris\u00e4ttning som kan ers\u00e4tta dagens behandling med dagliga eller veckovisa injektioner av liraglutid och andra GLP-1-analoger.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"red-bold-span\">STORT MEDICINSKT BEHOV<\/span><\/h3>\n\n\n\n<p>I en studie <sup>(2)<\/sup> bland patienter med typ 2-diabetes \u00a0som behandlas med GLP-1-analoger bed\u00f6mdes cirka 50 procent inte f\u00f6lja ordinerad behandling &#8211; trots att utebliven behandling kan leda till allvarliga f\u00f6ljdsjukdomar. Nanexa bed\u00f6mer, baserat p\u00e5 intervjuer med ledande l\u00e4kare, att injektioner en g\u00e5ng per m\u00e5nad ist\u00e4llet f\u00f6r dagligdags skulle ge en betydligt b\u00e4ttre f\u00f6ljsamhet av ordinerad behandling. Det skulle d\u00e4rmed vara ett viktigt tillskott till dagens behandlingsalternativ. \u00d6kad f\u00f6ljsamhet bidrar till en f\u00f6rb\u00e4ttrad behandlingseffekt och d\u00e4rigenom friskare patienter och stora besparingar f\u00f6r v\u00e5rden och samh\u00e4llet.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"red-bold-span\">BEKV\u00c4MLIGHET<\/span><\/h3>\n\n\n\n<p>Patienter med l\u00e5g f\u00f6ljsamhet av ordinerad behandling \u00e4r den huvudsakliga m\u00e5lgruppen f\u00f6r NEX-22. Men bed\u00f6mningen \u00e4r att den \u00f6kade bekv\u00e4mlighet som det inneb\u00e4r med betydligt f\u00e4rre injektioner g\u00f6r att NEX-22 utg\u00f6r ett attraktivt behandlingsalternativ f\u00f6r merparten av alla patienter.<\/p>\n\n\n\n\n<div class=\"source\"  style=\"margin:20px -20px\">\n    \n\n<p><strong>(1)<\/strong> Datamonitor Type 2-diabetes Disease analysis March 2021<br><strong>(2)<\/strong> Weiss\u00a0et.al. Patient Prefer Adherence . 2020 Nov 27;14:2337-2345<br><strong>(3)<\/strong> Global Data Type 2-diabetes forecast 2021<\/p>\n\n\n<\/div>\n\n<\/div><\/section>","protected":false},"excerpt":{"rendered":"<p>nex-22 f\u00f6r behandling <br \/>av typ 2-diabetes<\/p>\n<ol>\n<li><a href=\"#project-id-1\">Vad \u00e4r typ 2-diabetes<\/a><\/li>\n<li><a href=\"#project-id-2\">B\u00e4ttre efterlevnad och bekv\u00e4mare behandling<\/a><\/li>\n<\/ol>\n<p>\t\t\t<img decoding=\"async\" src=\"https:\/\/nanexa.com\/wp-content\/uploads\/2022\/10\/typ2diabetes_1.webp\" style=\"width:100%\"\/><\/p>\n<p>vad \u00e4r<\/p>\n<p>VAD \u00c4R typ 2-diabetes?<a class=\"read-more\" href=\"https:\/\/nanexa.com\/sv\/nex-22\/\">L\u00e4s mer<\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-6568","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>NEX-22 - Nanexa AB<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nanexa.com\/nex-22\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"NEX-22 - Nanexa AB\" \/>\n<meta property=\"og:description\" content=\"nex-22 f\u00f6r behandling av typ 2-diabetes            Vad \u00e4r typ 2-diabetesB\u00e4ttre efterlevnad och bekv\u00e4mare behandling              vad \u00e4r VAD \u00c4R typ 2-diabetes?L\u00e4s mer\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nanexa.com\/nex-22\/\" \/>\n<meta property=\"og:site_name\" content=\"Nanexa AB\" \/>\n<meta property=\"article:modified_time\" content=\"2022-12-01T14:16:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nanexa.com\/wp-content\/uploads\/2022\/10\/typ2diabetes_2.webp\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minuter\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/nex-22\\\/\",\"url\":\"https:\\\/\\\/nanexa.com\\\/nex-22\\\/\",\"name\":\"NEX-22 - Nanexa AB\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/nex-22\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/nex-22\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nanexa.com\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/typ2diabetes_2.webp\",\"datePublished\":\"2022-10-21T07:56:56+00:00\",\"dateModified\":\"2022-12-01T14:16:27+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/nex-22\\\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nanexa.com\\\/nex-22\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/nex-22\\\/#primaryimage\",\"url\":\"https:\\\/\\\/nanexa.com\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/typ2diabetes_2.webp\",\"contentUrl\":\"https:\\\/\\\/nanexa.com\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/typ2diabetes_2.webp\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/nex-22\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Hem\",\"item\":\"https:\\\/\\\/nanexa.com\\\/sv\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"NEX-22\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#website\",\"url\":\"https:\\\/\\\/nanexa.com\\\/\",\"name\":\"Nanexa AB\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nanexa.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\",\"name\":\"Nanexa AB\",\"url\":\"https:\\\/\\\/nanexa.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nanexa.com\\\/wp-content\\\/uploads\\\/2015\\\/04\\\/nanexa-logo.png\",\"contentUrl\":\"https:\\\/\\\/nanexa.com\\\/wp-content\\\/uploads\\\/2015\\\/04\\\/nanexa-logo.png\",\"width\":165,\"height\":50,\"caption\":\"Nanexa AB\"},\"image\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"NEX-22 - Nanexa AB","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nanexa.com\/nex-22\/","og_locale":"sv_SE","og_type":"article","og_title":"NEX-22 - Nanexa AB","og_description":"nex-22 f\u00f6r behandling av typ 2-diabetes            Vad \u00e4r typ 2-diabetesB\u00e4ttre efterlevnad och bekv\u00e4mare behandling              vad \u00e4r VAD \u00c4R typ 2-diabetes?L\u00e4s mer","og_url":"https:\/\/nanexa.com\/nex-22\/","og_site_name":"Nanexa AB","article_modified_time":"2022-12-01T14:16:27+00:00","og_image":[{"url":"https:\/\/nanexa.com\/wp-content\/uploads\/2022\/10\/typ2diabetes_2.webp","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_misc":{"Ber\u00e4knad l\u00e4stid":"3 minuter"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/nanexa.com\/nex-22\/","url":"https:\/\/nanexa.com\/nex-22\/","name":"NEX-22 - Nanexa AB","isPartOf":{"@id":"https:\/\/nanexa.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nanexa.com\/nex-22\/#primaryimage"},"image":{"@id":"https:\/\/nanexa.com\/nex-22\/#primaryimage"},"thumbnailUrl":"https:\/\/nanexa.com\/wp-content\/uploads\/2022\/10\/typ2diabetes_2.webp","datePublished":"2022-10-21T07:56:56+00:00","dateModified":"2022-12-01T14:16:27+00:00","breadcrumb":{"@id":"https:\/\/nanexa.com\/nex-22\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nanexa.com\/nex-22\/"]}]},{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/nanexa.com\/nex-22\/#primaryimage","url":"https:\/\/nanexa.com\/wp-content\/uploads\/2022\/10\/typ2diabetes_2.webp","contentUrl":"https:\/\/nanexa.com\/wp-content\/uploads\/2022\/10\/typ2diabetes_2.webp"},{"@type":"BreadcrumbList","@id":"https:\/\/nanexa.com\/nex-22\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Hem","item":"https:\/\/nanexa.com\/sv\/"},{"@type":"ListItem","position":2,"name":"NEX-22"}]},{"@type":"WebSite","@id":"https:\/\/nanexa.com\/#website","url":"https:\/\/nanexa.com\/","name":"Nanexa AB","description":"","publisher":{"@id":"https:\/\/nanexa.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nanexa.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"},{"@type":"Organization","@id":"https:\/\/nanexa.com\/#organization","name":"Nanexa AB","url":"https:\/\/nanexa.com\/","logo":{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/nanexa.com\/#\/schema\/logo\/image\/","url":"https:\/\/nanexa.com\/wp-content\/uploads\/2015\/04\/nanexa-logo.png","contentUrl":"https:\/\/nanexa.com\/wp-content\/uploads\/2015\/04\/nanexa-logo.png","width":165,"height":50,"caption":"Nanexa AB"},"image":{"@id":"https:\/\/nanexa.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/pages\/6568","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/comments?post=6568"}],"version-history":[{"count":26,"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/pages\/6568\/revisions"}],"predecessor-version":[{"id":6702,"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/pages\/6568\/revisions\/6702"}],"wp:attachment":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/media?parent=6568"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}